Arcutis Biotherapeutics I... (ARQT)

NASDAQ: ARQT · Real-Time Price · USD

15.31

0.66 (4.51%)

At close: May 02, 2025, 2:45 PM

Arcutis Biotherapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017
Net Income	-140.04M	-262.14M	-311.46M	-206.36M	-135.68M	-42M	-19.25M	-4.98M
Depreciation & Amortization	2.6M	1.52M	934K	454K	122K	195K	n/a	n/a
Stock-Based Compensation	41.73M	38.81M	32.68M	23.89M	7.94M	824K	151K	27K
Other Working Capital	30.35M	-3.68M	4.23M	3.38M	8.46M	-1.05M	844K	-258K
Other Non-Cash Items	-1.37M	-1.75M	30.3M	309K	333K	-354K	2.91M	897K
Deferred Income Tax	n/a	n/a	n/a	3.45M	114K	n/a	n/a	n/a
Change in Working Capital	-15.08M	-23.5M	-10.18M	3.62M	14.13M	-1.5M	2.11M	279K
Operating Cash Flow	-112.16M	-247.06M	-257.71M	-174.63M	-113.03M	-42.84M	-14.09M	-3.77M
Capital Expenditures	-143K	-428K	-23.28M	-995K	-321K	-295K	n/a	n/a
Cash Acquisitions	n/a	n/a	22.95M	74.96M	181.5M	26.03M	n/a	n/a
Purchase of Investments	-254.82M	-225.84M	-415.39M	-292.51M	-279.1M	-60.83M	-11.53M	n/a
Sales Maturities Of Investments	288.78M	406.5M	351.47M	217.55M	97.6M	34.8M	n/a	n/a
Other Investing Acitivies	-5M	n/a	-22.95M	-74.96M	-181.5M	-26.03M	-11.53M	n/a
Investing Cash Flow	28.82M	180.23M	-87.2M	-75.95M	-181.82M	-26.32M	-11.53M	n/a
Debt Repayment	-100M	n/a	125M	73.99M	n/a	n/a	n/a	50K
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	4.52M	2.42M	751K	470K	1.14M	-1.14M	386K	7.07M
Financial Cash Flow	66.2M	101.32M	301.8M	281.95M	298.14M	93.1M	61.59M	7.12M
Net Cash Flow	-17.37M	34.45M	-43.12M	31.37M	3.29M	23.94M	35.98M	3.34M
Free Cash Flow	-112.3M	-247.49M	-281M	-175.62M	-113.35M	-43.13M	-14.09M	-3.77M